nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0643	0.274	CbGeAlD
Risperidone—HTR2B—cardial valve—dilated cardiomyopathy	0.0415	0.177	CbGeAlD
Risperidone—KCNH2—endocardium—dilated cardiomyopathy	0.0331	0.141	CbGeAlD
Risperidone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0177	0.532	CbGbCtD
Risperidone—ABCB1—Spironolactone—dilated cardiomyopathy	0.0156	0.468	CbGbCtD
Risperidone—HTR7—pulmonary artery—dilated cardiomyopathy	0.0144	0.0612	CbGeAlD
Risperidone—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.014	0.0596	CbGeAlD
Risperidone—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00898	0.0382	CbGeAlD
Risperidone—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00873	0.0371	CbGeAlD
Risperidone—DRD4—heart—dilated cardiomyopathy	0.00625	0.0266	CbGeAlD
Risperidone—H1F0—cardiac ventricle—dilated cardiomyopathy	0.00485	0.0206	CbGeAlD
Risperidone—H1F0—myocardium—dilated cardiomyopathy	0.00456	0.0194	CbGeAlD
Risperidone—H1F0—heart—dilated cardiomyopathy	0.00319	0.0136	CbGeAlD
Risperidone—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00279	0.0119	CbGeAlD
Risperidone—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00275	0.0117	CbGeAlD
Risperidone—H1F0—cardiac atrium—dilated cardiomyopathy	0.00272	0.0116	CbGeAlD
Risperidone—KCNH2—myocardium—dilated cardiomyopathy	0.00262	0.0112	CbGeAlD
Risperidone—ADRA2C—myocardium—dilated cardiomyopathy	0.00259	0.011	CbGeAlD
Risperidone—HTR2B—heart—dilated cardiomyopathy	0.0023	0.00977	CbGeAlD
Risperidone—HTR7—heart—dilated cardiomyopathy	0.00197	0.00836	CbGeAlD
Risperidone—ADRA1A—heart—dilated cardiomyopathy	0.0019	0.00807	CbGeAlD
Risperidone—KCNH2—heart—dilated cardiomyopathy	0.00183	0.00779	CbGeAlD
Risperidone—ADRA2C—heart—dilated cardiomyopathy	0.00181	0.00769	CbGeAlD
Risperidone—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00164	0.0037	CcSEcCtD
Risperidone—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00161	0.00364	CcSEcCtD
Risperidone—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00157	0.00666	CbGeAlD
Risperidone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00156	0.00352	CcSEcCtD
Risperidone—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.00155	0.00657	CbGeAlD
Risperidone—Thirst—Furosemide—dilated cardiomyopathy	0.00154	0.00348	CcSEcCtD
Risperidone—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00153	0.00346	CcSEcCtD
Risperidone—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00153	0.00346	CcSEcCtD
Risperidone—Neck pain—Lisinopril—dilated cardiomyopathy	0.00153	0.00346	CcSEcCtD
Risperidone—Purpura—Furosemide—dilated cardiomyopathy	0.00152	0.00343	CcSEcCtD
Risperidone—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00152	0.00342	CcSEcCtD
Risperidone—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00152	0.00342	CcSEcCtD
Risperidone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00151	0.00342	CcSEcCtD
Risperidone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00151	0.0034	CcSEcCtD
Risperidone—Lethargy—Furosemide—dilated cardiomyopathy	0.0015	0.00338	CcSEcCtD
Risperidone—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00148	0.00334	CcSEcCtD
Risperidone—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00147	0.00332	CcSEcCtD
Risperidone—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00147	0.00332	CcSEcCtD
Risperidone—Wheezing—Lisinopril—dilated cardiomyopathy	0.00147	0.00332	CcSEcCtD
Risperidone—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00147	0.00332	CcSEcCtD
Risperidone—Malaise—Spironolactone—dilated cardiomyopathy	0.00146	0.0033	CcSEcCtD
Risperidone—Cystitis—Lisinopril—dilated cardiomyopathy	0.00146	0.0033	CcSEcCtD
Risperidone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00145	0.00328	CcSEcCtD
Risperidone—ADRA2A—heart—dilated cardiomyopathy	0.00144	0.00613	CbGeAlD
Risperidone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00144	0.00325	CcSEcCtD
Risperidone—Photophobia—Lisinopril—dilated cardiomyopathy	0.00142	0.00321	CcSEcCtD
Risperidone—Urinary retention—Furosemide—dilated cardiomyopathy	0.00139	0.00315	CcSEcCtD
Risperidone—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00137	0.00309	CcSEcCtD
Risperidone—Discomfort—Spironolactone—dilated cardiomyopathy	0.00136	0.00308	CcSEcCtD
Risperidone—Dehydration—Furosemide—dilated cardiomyopathy	0.00136	0.00308	CcSEcCtD
Risperidone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00135	0.00304	CcSEcCtD
Risperidone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00134	0.00302	CcSEcCtD
Risperidone—Confusional state—Spironolactone—dilated cardiomyopathy	0.00134	0.00301	CcSEcCtD
Risperidone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00133	0.00301	CcSEcCtD
Risperidone—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00133	0.003	CcSEcCtD
Risperidone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00132	0.00299	CcSEcCtD
Risperidone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0013	0.00293	CcSEcCtD
Risperidone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00129	0.00292	CcSEcCtD
Risperidone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00128	0.00288	CcSEcCtD
Risperidone—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00127	0.00287	CcSEcCtD
Risperidone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00126	0.00285	CcSEcCtD
Risperidone—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00125	0.00283	CcSEcCtD
Risperidone—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00124	0.0028	CcSEcCtD
Risperidone—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00124	0.0028	CcSEcCtD
Risperidone—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.00123	0.00525	CbGeAlD
Risperidone—HTR2A—heart—dilated cardiomyopathy	0.00123	0.00521	CbGeAlD
Risperidone—Eczema—Lisinopril—dilated cardiomyopathy	0.00122	0.00276	CcSEcCtD
Risperidone—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00122	0.00276	CcSEcCtD
Risperidone—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00121	0.00272	CcSEcCtD
Risperidone—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00119	0.00269	CcSEcCtD
Risperidone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00119	0.00268	CcSEcCtD
Risperidone—Somnolence—Spironolactone—dilated cardiomyopathy	0.00118	0.00266	CcSEcCtD
Risperidone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00117	0.00264	CcSEcCtD
Risperidone—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00116	0.00262	CcSEcCtD
Risperidone—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00116	0.00261	CcSEcCtD
Risperidone—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00116	0.00261	CcSEcCtD
Risperidone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00114	0.00258	CcSEcCtD
Risperidone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00114	0.00258	CcSEcCtD
Risperidone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00114	0.00256	CcSEcCtD
Risperidone—Arthritis—Lisinopril—dilated cardiomyopathy	0.00113	0.00255	CcSEcCtD
Risperidone—Drowsiness—Furosemide—dilated cardiomyopathy	0.00113	0.00255	CcSEcCtD
Risperidone—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00113	0.00254	CcSEcCtD
Risperidone—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00112	0.00253	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00112	0.00253	CcSEcCtD
Risperidone—Renal failure—Furosemide—dilated cardiomyopathy	0.00111	0.00251	CcSEcCtD
Risperidone—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.0011	0.00249	CcSEcCtD
Risperidone—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.0011	0.00248	CcSEcCtD
Risperidone—Diplopia—Lisinopril—dilated cardiomyopathy	0.0011	0.00248	CcSEcCtD
Risperidone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.0011	0.00248	CcSEcCtD
Risperidone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00109	0.00246	CcSEcCtD
Risperidone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00109	0.00246	CcSEcCtD
Risperidone—Sweating—Furosemide—dilated cardiomyopathy	0.00108	0.00244	CcSEcCtD
Risperidone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00107	0.00241	CcSEcCtD
Risperidone—Face oedema—Lisinopril—dilated cardiomyopathy	0.00106	0.0024	CcSEcCtD
Risperidone—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00105	0.00238	CcSEcCtD
Risperidone—Urticaria—Spironolactone—dilated cardiomyopathy	0.00105	0.00237	CcSEcCtD
Risperidone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00105	0.00236	CcSEcCtD
Risperidone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00105	0.00236	CcSEcCtD
Risperidone—Ataxia—Lisinopril—dilated cardiomyopathy	0.00103	0.00233	CcSEcCtD
Risperidone—Dehydration—Lisinopril—dilated cardiomyopathy	0.00102	0.00231	CcSEcCtD
Risperidone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.001	0.00227	CcSEcCtD
Risperidone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.001	0.00226	CcSEcCtD
Risperidone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000994	0.00224	CcSEcCtD
Risperidone—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000994	0.00224	CcSEcCtD
Risperidone—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000984	0.00222	CcSEcCtD
Risperidone—Visual impairment—Furosemide—dilated cardiomyopathy	0.000977	0.00221	CcSEcCtD
Risperidone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000976	0.0022	CcSEcCtD
Risperidone—Gastritis—Lisinopril—dilated cardiomyopathy	0.000973	0.0022	CcSEcCtD
Risperidone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000959	0.00216	CcSEcCtD
Risperidone—Asthma—Lisinopril—dilated cardiomyopathy	0.000951	0.00215	CcSEcCtD
Risperidone—Influenza—Lisinopril—dilated cardiomyopathy	0.000951	0.00215	CcSEcCtD
Risperidone—Eye disorder—Furosemide—dilated cardiomyopathy	0.000948	0.00214	CcSEcCtD
Risperidone—Tinnitus—Furosemide—dilated cardiomyopathy	0.000946	0.00213	CcSEcCtD
Risperidone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000937	0.00211	CcSEcCtD
Risperidone—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000935	0.00211	CcSEcCtD
Risperidone—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000932	0.0021	CcSEcCtD
Risperidone—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000926	0.00209	CcSEcCtD
Risperidone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000926	0.00209	CcSEcCtD
Risperidone—Angiopathy—Furosemide—dilated cardiomyopathy	0.00092	0.00208	CcSEcCtD
Risperidone—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000916	0.00207	CcSEcCtD
Risperidone—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000914	0.00206	CcSEcCtD
Risperidone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000906	0.00204	CcSEcCtD
Risperidone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000906	0.00204	CcSEcCtD
Risperidone—Dysuria—Lisinopril—dilated cardiomyopathy	0.000889	0.00201	CcSEcCtD
Risperidone—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000889	0.00201	CcSEcCtD
Risperidone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000884	0.00199	CcSEcCtD
Risperidone—Erythema—Furosemide—dilated cardiomyopathy	0.000883	0.00199	CcSEcCtD
Risperidone—Malnutrition—Furosemide—dilated cardiomyopathy	0.000883	0.00199	CcSEcCtD
Risperidone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000876	0.00198	CcSEcCtD
Risperidone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000876	0.00198	CcSEcCtD
Risperidone—Flatulence—Furosemide—dilated cardiomyopathy	0.00087	0.00196	CcSEcCtD
Risperidone—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000868	0.00196	CcSEcCtD
Risperidone—Weight increased—Lisinopril—dilated cardiomyopathy	0.000865	0.00195	CcSEcCtD
Risperidone—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000865	0.00195	CcSEcCtD
Risperidone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00086	0.00194	CcSEcCtD
Risperidone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000858	0.00194	CcSEcCtD
Risperidone—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000853	0.00192	CcSEcCtD
Risperidone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000849	0.00192	CcSEcCtD
Risperidone—Depression—Lisinopril—dilated cardiomyopathy	0.000845	0.00191	CcSEcCtD
Risperidone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000842	0.0019	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00084	0.0019	CcSEcCtD
Risperidone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000836	0.00189	CcSEcCtD
Risperidone—Rash—Spironolactone—dilated cardiomyopathy	0.000835	0.00188	CcSEcCtD
Risperidone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000834	0.00188	CcSEcCtD
Risperidone—Renal failure—Lisinopril—dilated cardiomyopathy	0.000833	0.00188	CcSEcCtD
Risperidone—Vision blurred—Furosemide—dilated cardiomyopathy	0.000832	0.00188	CcSEcCtD
Risperidone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000831	0.00188	CcSEcCtD
Risperidone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000831	0.00188	CcSEcCtD
Risperidone—Headache—Spironolactone—dilated cardiomyopathy	0.00083	0.00187	CcSEcCtD
Risperidone—Jaundice—Lisinopril—dilated cardiomyopathy	0.000826	0.00186	CcSEcCtD
Risperidone—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000824	0.00186	CcSEcCtD
Risperidone—Anaemia—Furosemide—dilated cardiomyopathy	0.000816	0.00184	CcSEcCtD
Risperidone—Sweating—Lisinopril—dilated cardiomyopathy	0.000813	0.00183	CcSEcCtD
Risperidone—Agitation—Furosemide—dilated cardiomyopathy	0.000811	0.00183	CcSEcCtD
Risperidone—Haematuria—Lisinopril—dilated cardiomyopathy	0.000808	0.00182	CcSEcCtD
Risperidone—ABCB1—heart—dilated cardiomyopathy	0.000803	0.00342	CbGeAlD
Risperidone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000802	0.00181	CcSEcCtD
Risperidone—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0008	0.0018	CcSEcCtD
Risperidone—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000795	0.00179	CcSEcCtD
Risperidone—Vertigo—Furosemide—dilated cardiomyopathy	0.000793	0.00179	CcSEcCtD
Risperidone—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000791	0.00179	CcSEcCtD
Risperidone—Leukopenia—Furosemide—dilated cardiomyopathy	0.00079	0.00178	CcSEcCtD
Risperidone—Nausea—Spironolactone—dilated cardiomyopathy	0.000787	0.00178	CcSEcCtD
Risperidone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000775	0.00175	CcSEcCtD
Risperidone—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000763	0.00172	CcSEcCtD
Risperidone—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000761	0.00172	CcSEcCtD
Risperidone—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000755	0.0017	CcSEcCtD
Risperidone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000751	0.0017	CcSEcCtD
Risperidone—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00075	0.00169	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000746	0.00168	CcSEcCtD
Risperidone—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000746	0.00168	CcSEcCtD
Risperidone—Dry mouth—Furosemide—dilated cardiomyopathy	0.000735	0.00166	CcSEcCtD
Risperidone—Confusional state—Furosemide—dilated cardiomyopathy	0.000727	0.00164	CcSEcCtD
Risperidone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000721	0.00163	CcSEcCtD
Risperidone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000719	0.00162	CcSEcCtD
Risperidone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000709	0.0016	CcSEcCtD
Risperidone—Shock—Furosemide—dilated cardiomyopathy	0.000709	0.0016	CcSEcCtD
Risperidone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000707	0.00159	CcSEcCtD
Risperidone—Flushing—Lisinopril—dilated cardiomyopathy	0.000706	0.00159	CcSEcCtD
Risperidone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000705	0.00159	CcSEcCtD
Risperidone—Skin disorder—Furosemide—dilated cardiomyopathy	0.0007	0.00158	CcSEcCtD
Risperidone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000697	0.00157	CcSEcCtD
Risperidone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00069	0.00156	CcSEcCtD
Risperidone—Anorexia—Furosemide—dilated cardiomyopathy	0.000687	0.00155	CcSEcCtD
Risperidone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000686	0.00155	CcSEcCtD
Risperidone—Chills—Lisinopril—dilated cardiomyopathy	0.000683	0.00154	CcSEcCtD
Risperidone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00068	0.00153	CcSEcCtD
Risperidone—Hypotension—Furosemide—dilated cardiomyopathy	0.000673	0.00152	CcSEcCtD
Risperidone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000672	0.00152	CcSEcCtD
Risperidone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000667	0.0015	CcSEcCtD
Risperidone—Erythema—Lisinopril—dilated cardiomyopathy	0.000662	0.00149	CcSEcCtD
Risperidone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000662	0.00149	CcSEcCtD
Risperidone—Flatulence—Lisinopril—dilated cardiomyopathy	0.000653	0.00147	CcSEcCtD
Risperidone—Tension—Lisinopril—dilated cardiomyopathy	0.00065	0.00147	CcSEcCtD
Risperidone—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000649	0.00146	CcSEcCtD
Risperidone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000647	0.00146	CcSEcCtD
Risperidone—Nervousness—Lisinopril—dilated cardiomyopathy	0.000643	0.00145	CcSEcCtD
Risperidone—Back pain—Lisinopril—dilated cardiomyopathy	0.000641	0.00145	CcSEcCtD
Risperidone—Somnolence—Furosemide—dilated cardiomyopathy	0.000641	0.00145	CcSEcCtD
Risperidone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000637	0.00144	CcSEcCtD
Risperidone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000626	0.00141	CcSEcCtD
Risperidone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000624	0.00141	CcSEcCtD
Risperidone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000622	0.0014	CcSEcCtD
Risperidone—Fatigue—Furosemide—dilated cardiomyopathy	0.000621	0.0014	CcSEcCtD
Risperidone—Tremor—Lisinopril—dilated cardiomyopathy	0.000621	0.0014	CcSEcCtD
Risperidone—Constipation—Furosemide—dilated cardiomyopathy	0.000616	0.00139	CcSEcCtD
Risperidone—Pain—Furosemide—dilated cardiomyopathy	0.000616	0.00139	CcSEcCtD
Risperidone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000615	0.00139	CcSEcCtD
Risperidone—Anaemia—Lisinopril—dilated cardiomyopathy	0.000612	0.00138	CcSEcCtD
Risperidone—Angioedema—Lisinopril—dilated cardiomyopathy	0.000605	0.00137	CcSEcCtD
Risperidone—Malaise—Lisinopril—dilated cardiomyopathy	0.000597	0.00135	CcSEcCtD
Risperidone—Vertigo—Lisinopril—dilated cardiomyopathy	0.000595	0.00134	CcSEcCtD
Risperidone—Syncope—Lisinopril—dilated cardiomyopathy	0.000594	0.00134	CcSEcCtD
Risperidone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000594	0.00134	CcSEcCtD
Risperidone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000593	0.00134	CcSEcCtD
Risperidone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000589	0.00133	CcSEcCtD
Risperidone—Palpitations—Lisinopril—dilated cardiomyopathy	0.000585	0.00132	CcSEcCtD
Risperidone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000582	0.00131	CcSEcCtD
Risperidone—Cough—Lisinopril—dilated cardiomyopathy	0.000578	0.0013	CcSEcCtD
Risperidone—Urticaria—Furosemide—dilated cardiomyopathy	0.000572	0.00129	CcSEcCtD
Risperidone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00057	0.00129	CcSEcCtD
Risperidone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00057	0.00129	CcSEcCtD
Risperidone—Myalgia—Lisinopril—dilated cardiomyopathy	0.000564	0.00127	CcSEcCtD
Risperidone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000564	0.00127	CcSEcCtD
Risperidone—Chest pain—Lisinopril—dilated cardiomyopathy	0.000564	0.00127	CcSEcCtD
Risperidone—Anxiety—Lisinopril—dilated cardiomyopathy	0.000562	0.00127	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00056	0.00126	CcSEcCtD
Risperidone—Discomfort—Lisinopril—dilated cardiomyopathy	0.000557	0.00126	CcSEcCtD
Risperidone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000552	0.00124	CcSEcCtD
Risperidone—Confusional state—Lisinopril—dilated cardiomyopathy	0.000545	0.00123	CcSEcCtD
Risperidone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000541	0.00122	CcSEcCtD
Risperidone—Oedema—Lisinopril—dilated cardiomyopathy	0.000541	0.00122	CcSEcCtD
Risperidone—Infection—Lisinopril—dilated cardiomyopathy	0.000537	0.00121	CcSEcCtD
Risperidone—Shock—Lisinopril—dilated cardiomyopathy	0.000532	0.0012	CcSEcCtD
Risperidone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000531	0.0012	CcSEcCtD
Risperidone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000529	0.00119	CcSEcCtD
Risperidone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000528	0.00119	CcSEcCtD
Risperidone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000525	0.00119	CcSEcCtD
Risperidone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000523	0.00118	CcSEcCtD
Risperidone—Asthenia—Furosemide—dilated cardiomyopathy	0.000517	0.00117	CcSEcCtD
Risperidone—Anorexia—Lisinopril—dilated cardiomyopathy	0.000515	0.00116	CcSEcCtD
Risperidone—Pruritus—Furosemide—dilated cardiomyopathy	0.00051	0.00115	CcSEcCtD
Risperidone—Hypotension—Lisinopril—dilated cardiomyopathy	0.000505	0.00114	CcSEcCtD
Risperidone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000493	0.00111	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000493	0.00111	CcSEcCtD
Risperidone—Insomnia—Lisinopril—dilated cardiomyopathy	0.000489	0.0011	CcSEcCtD
Risperidone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000485	0.0011	CcSEcCtD
Risperidone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000482	0.00109	CcSEcCtD
Risperidone—Somnolence—Lisinopril—dilated cardiomyopathy	0.000481	0.00108	CcSEcCtD
Risperidone—Dizziness—Furosemide—dilated cardiomyopathy	0.000476	0.00108	CcSEcCtD
Risperidone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000476	0.00107	CcSEcCtD
Risperidone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00047	0.00106	CcSEcCtD
Risperidone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000467	0.00105	CcSEcCtD
Risperidone—Fatigue—Lisinopril—dilated cardiomyopathy	0.000466	0.00105	CcSEcCtD
Risperidone—Pain—Lisinopril—dilated cardiomyopathy	0.000462	0.00104	CcSEcCtD
Risperidone—Constipation—Lisinopril—dilated cardiomyopathy	0.000462	0.00104	CcSEcCtD
Risperidone—Vomiting—Furosemide—dilated cardiomyopathy	0.000458	0.00103	CcSEcCtD
Risperidone—Rash—Furosemide—dilated cardiomyopathy	0.000454	0.00103	CcSEcCtD
Risperidone—Dermatitis—Furosemide—dilated cardiomyopathy	0.000454	0.00102	CcSEcCtD
Risperidone—Headache—Furosemide—dilated cardiomyopathy	0.000451	0.00102	CcSEcCtD
Risperidone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000446	0.00101	CcSEcCtD
Risperidone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000442	0.000998	CcSEcCtD
Risperidone—Urticaria—Lisinopril—dilated cardiomyopathy	0.000429	0.000969	CcSEcCtD
Risperidone—Nausea—Furosemide—dilated cardiomyopathy	0.000428	0.000966	CcSEcCtD
Risperidone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000427	0.000964	CcSEcCtD
Risperidone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000427	0.000964	CcSEcCtD
Risperidone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000398	0.000899	CcSEcCtD
Risperidone—Asthenia—Lisinopril—dilated cardiomyopathy	0.000388	0.000875	CcSEcCtD
Risperidone—Pruritus—Lisinopril—dilated cardiomyopathy	0.000382	0.000863	CcSEcCtD
Risperidone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00037	0.000835	CcSEcCtD
Risperidone—Dizziness—Lisinopril—dilated cardiomyopathy	0.000358	0.000807	CcSEcCtD
Risperidone—Vomiting—Lisinopril—dilated cardiomyopathy	0.000344	0.000776	CcSEcCtD
Risperidone—Rash—Lisinopril—dilated cardiomyopathy	0.000341	0.000769	CcSEcCtD
Risperidone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000341	0.000769	CcSEcCtD
Risperidone—Headache—Lisinopril—dilated cardiomyopathy	0.000339	0.000764	CcSEcCtD
Risperidone—Nausea—Lisinopril—dilated cardiomyopathy	0.000321	0.000725	CcSEcCtD
Risperidone—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.93e-05	0.000171	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.93e-05	0.000171	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.92e-05	0.000171	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.92e-05	0.000171	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.9e-05	0.00017	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.88e-05	0.000169	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.84e-05	0.000168	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.83e-05	0.000168	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.82e-05	0.000167	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.81e-05	0.000167	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.81e-05	0.000167	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.79e-05	0.000166	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.79e-05	0.000166	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.77e-05	0.000165	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.76e-05	0.000165	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.75e-05	0.000165	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.74e-05	0.000164	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.72e-05	0.000164	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.72e-05	0.000164	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.72e-05	0.000164	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.72e-05	0.000164	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	4.7e-05	0.000163	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.7e-05	0.000163	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.67e-05	0.000162	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.62e-05	0.00016	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.6e-05	0.00016	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.59e-05	0.000159	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.59e-05	0.000159	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.58e-05	0.000159	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.54e-05	0.000157	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.52e-05	0.000157	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.52e-05	0.000157	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	4.51e-05	0.000156	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.51e-05	0.000156	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	4.5e-05	0.000156	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.46e-05	0.000155	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.46e-05	0.000155	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.45e-05	0.000154	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.45e-05	0.000154	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.44e-05	0.000154	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.43e-05	0.000154	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.42e-05	0.000153	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	4.39e-05	0.000152	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.39e-05	0.000152	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.38e-05	0.000152	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.38e-05	0.000152	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.37e-05	0.000151	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.35e-05	0.000151	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.35e-05	0.000151	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	4.32e-05	0.00015	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.32e-05	0.00015	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.31e-05	0.00015	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	4.31e-05	0.000149	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.31e-05	0.000149	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.28e-05	0.000148	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.28e-05	0.000148	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.27e-05	0.000148	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.27e-05	0.000148	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.25e-05	0.000147	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.25e-05	0.000147	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.24e-05	0.000147	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.23e-05	0.000146	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.22e-05	0.000146	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.2e-05	0.000146	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.19e-05	0.000145	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.19e-05	0.000145	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.19e-05	0.000145	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.17e-05	0.000145	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.16e-05	0.000144	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.15e-05	0.000144	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.13e-05	0.000143	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.11e-05	0.000142	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.1e-05	0.000142	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.09e-05	0.000142	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.08e-05	0.000141	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.07e-05	0.000141	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.04e-05	0.00014	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.02e-05	0.000139	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.01e-05	0.000139	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.98e-05	0.000138	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.98e-05	0.000138	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.97e-05	0.000138	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.94e-05	0.000137	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.93e-05	0.000136	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.92e-05	0.000136	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.91e-05	0.000136	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.91e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.89e-05	0.000135	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.89e-05	0.000135	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.89e-05	0.000135	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.88e-05	0.000135	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.85e-05	0.000134	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.84e-05	0.000133	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.84e-05	0.000133	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.83e-05	0.000133	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.81e-05	0.000132	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.79e-05	0.000131	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	3.78e-05	0.000131	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.77e-05	0.000131	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.76e-05	0.00013	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.74e-05	0.00013	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.73e-05	0.000129	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.68e-05	0.000128	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.68e-05	0.000128	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.66e-05	0.000127	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	3.64e-05	0.000126	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.63e-05	0.000126	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	3.62e-05	0.000126	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.62e-05	0.000125	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	3.62e-05	0.000125	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.61e-05	0.000125	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.61e-05	0.000125	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.61e-05	0.000125	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.59e-05	0.000125	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	3.59e-05	0.000125	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	3.57e-05	0.000124	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.56e-05	0.000123	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	3.55e-05	0.000123	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	3.54e-05	0.000123	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	3.52e-05	0.000122	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.5e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.5e-05	0.000121	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	3.46e-05	0.00012	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.46e-05	0.00012	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	3.44e-05	0.000119	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.44e-05	0.000119	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.34e-05	0.000116	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	3.3e-05	0.000115	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.29e-05	0.000114	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.28e-05	0.000114	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.26e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.26e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.22e-05	0.000112	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.22e-05	0.000112	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.22e-05	0.000111	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	3.19e-05	0.000111	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.17e-05	0.00011	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.15e-05	0.000109	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.13e-05	0.000109	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.12e-05	0.000108	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	3.12e-05	0.000108	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.11e-05	0.000108	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.1e-05	0.000108	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	3.1e-05	0.000108	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.09e-05	0.000107	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	3.07e-05	0.000107	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.06e-05	0.000106	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.05e-05	0.000106	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3e-05	0.000104	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3e-05	0.000104	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.99e-05	0.000104	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.96e-05	0.000102	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.91e-05	0.000101	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.91e-05	0.000101	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.89e-05	0.0001	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	2.87e-05	9.96e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.84e-05	9.84e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.83e-05	9.83e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.8e-05	9.72e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	2.8e-05	9.7e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.79e-05	9.67e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.79e-05	9.67e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	2.78e-05	9.62e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.76e-05	9.58e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.73e-05	9.45e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.72e-05	9.43e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	2.71e-05	9.41e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.71e-05	9.41e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.68e-05	9.3e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.68e-05	9.29e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.68e-05	9.28e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	2.67e-05	9.26e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.67e-05	9.24e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.66e-05	9.23e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.66e-05	9.23e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	2.63e-05	9.13e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.63e-05	9.1e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	2.59e-05	8.99e-05	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.58e-05	8.95e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	2.56e-05	8.89e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	2.55e-05	8.85e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	2.52e-05	8.73e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.51e-05	8.7e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	2.51e-05	8.7e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.49e-05	8.64e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.48e-05	8.59e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.47e-05	8.58e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.46e-05	8.54e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.44e-05	8.46e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.44e-05	8.46e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.42e-05	8.4e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.42e-05	8.38e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	2.4e-05	8.33e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.37e-05	8.23e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	2.35e-05	8.16e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.31e-05	8.03e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	2.31e-05	8.01e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	2.31e-05	8e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.29e-05	7.95e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.27e-05	7.86e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.24e-05	7.75e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.2e-05	7.64e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.16e-05	7.5e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.16e-05	7.48e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.15e-05	7.45e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.13e-05	7.4e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.11e-05	7.3e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.09e-05	7.24e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.06e-05	7.13e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.99e-05	6.89e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.93e-05	6.71e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.93e-05	6.68e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.9e-05	6.57e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.87e-05	6.49e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.87e-05	6.47e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.86e-05	6.45e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.86e-05	6.45e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.85e-05	6.41e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.83e-05	6.33e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.82e-05	6.32e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	1.8e-05	6.24e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.77e-05	6.14e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.74e-05	6.04e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	1.72e-05	5.97e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.71e-05	5.93e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.7e-05	5.88e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.67e-05	5.8e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	1.65e-05	5.71e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.64e-05	5.69e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.63e-05	5.66e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.61e-05	5.57e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.6e-05	5.56e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.57e-05	5.45e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.57e-05	5.45e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.48e-05	5.14e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.46e-05	5.07e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.46e-05	5.07e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.32e-05	4.58e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.28e-05	4.42e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.27e-05	4.4e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	1.23e-05	4.28e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.22e-05	4.24e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.21e-05	4.21e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.19e-05	4.13e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	3.88e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.1e-05	3.82e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.1e-05	3.81e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.08e-05	3.74e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.07e-05	3.72e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1e-05	3.48e-05	CbGpPWpGaD
